Akoustis (AKTSQ) 10-Q 1 May 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Mar. 31, 2020	Apr. 24, 2020
Document Information Line Items
Entity Registrant Name	AKOUSTIS TECHNOLOGIES, INC.
Trading Symbol	AKTS
Document Type	10-Q
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding		36,389,000
Amendment Flag	false
Entity Central Index Key	0001584754
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-38029
City Area Code	704
Local Phone Number	997-5735
Entity Interactive Data Current	Yes
Entity Address, Address Line One	9805 Northcross Center Court
Entity Address, Address Line Two	Suite A
Entity Address, City or Town	Huntersville
Entity Address, Postal Zip Code	28078
Entity Address, State or Province	NC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	33-1229046
Security Exchange Name	NASDAQ
Title of 12(b) Security	Common Stock, $0.001 par value

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019
Assets:
Cash and cash equivalents	$ 39,577	$ 30,054
Accounts receivable	692	285
Inventory	76	94
Other current assets	812	1,289
Total current assets	41,157	31,722
Property and equipment, net	19,942	15,178
Intangibles, net	494	388
Assets held for sale, net	21	300
Operating lease right-of-use asset, net	751
Restricted cash	100	100
Other assets	449	261
Total Assets	62,914	47,949
Current Liabilities:
Accounts payable and accrued expenses	3,393	3,211
Deferred revenue		5
Contingent real estate liability		446
Operating lease liability-current	223
Total current liabilities	3,616	3,662
Long-term Liabilities:
Convertible notes payable, net	20,152	18,215
Operating lease liability - non current	534
Other long-term liabilities	117	117
Total long-term liabilities	20,803	18,332
Total Liabilities	24,419	21,994
Stockholders’ Equity
Preferred Stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 36,351,976 and 30,140,955 shares issued and outstanding at March 31, 2020 and June 30, 2019, respectively	36	30
Additional paid in capital	131,997	93,399
Accumulated deficit	(93,538)	(67,474)
Total Stockholders’ Equity	38,495	25,955
Total Liabilities and Stockholders’ Equity	$ 62,914	$ 47,949

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2020	Jun. 30, 2019
Preferred stock par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	36,351,976	30,140,955
Common stock, shares outstanding	36,351,976	30,140,955

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Revenue
Revenue with customers	$ 363	$ 237	$ 1,424	$ 764
Grant revenue				109
Total revenue	363	237	1,424	873
Cost of revenue	217	299	1,340	813
Gross profit (loss)	146	(62)	84	60
Operating expenses
Research and development	5,769	5,505	15,736	14,340
General and administrative expenses	2,589	2,503	8,158	6,841
Total operating expenses	8,358	8,008	23,894	21,181
Loss from operations	(8,212)	(8,070)	(23,810)	(21,121)
Other (expense) income
Interest (expense) income	(1,162)	(781)	(3,259)	(2,006)
Rental income	54	70	164	207
Change in fair value of contingent real estate liability	480	905	446	805
Change in fair value of derivative liabilities	1,066	(1,558)	396	(1,372)
Total other (expense) income	438	(1,364)	(2,253)	(2,366)
Net loss	$ (7,774)	$ (9,434)	$ (26,063)	$ (23,487)
Net loss per common share - basic and diluted (in Dollars per share)	$ (0.21)	$ (0.31)	$ (0.80)	$ (0.88)
Weighted average common shares outstanding - basic and diluted (in Shares)	36,263,779	29,959,908	32,659,339	26,659,999

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Jun. 30, 2018	$ 22	$ 52,074	$ (38,246)	$ 13,850
Balance (in Shares) at Jun. 30, 2018	22,203
Cumulative-effect adjustment from adoption of ASC 60			20	20
Common stock issued for services		1,947		1,947
Common stock issued for services (in Shares)	112
Common stock issued for exercise of warrants		71		71
Common stock issued for exercise of warrants (in Shares)	19
Vesting of restricted shares		351		351
Common stock issued in payment of note interest		290		290
Common stock issued in payment of note interest (in Shares)	40
Net loss			(7,308)	(7,308)
Balance at Sep. 30, 2018	$ 22	54,652	(45,534)	9,140
Balance (in Shares) at Sep. 30, 2018	22,374
Common stock issued for cash, net of issuance costs		(81)		(81)
Balance at Jun. 30, 2018	$ 22	52,074	(38,246)	13,850
Balance (in Shares) at Jun. 30, 2018	22,203
Net loss				(23,487)
Balance at Mar. 31, 2019	$ 30	91,383	(61,713)	29,700
Balance (in Shares) at Mar. 31, 2019	30,008
Balance at Sep. 30, 2018	$ 22	54,652	(45,534)	9,140
Balance (in Shares) at Sep. 30, 2018	22,374
Common stock issued for services		1,044		1,044
Common stock issued for services (in Shares)	121
Intrinsic value of beneficial conversion feature		3,951		3,951
Vesting of restricted shares		177		177
Common stock issued in payment of note interest		244		244
Common stock issued in payment of note interest (in Shares)	53
Net loss			(6,745)	(6,745)
Balance at Dec. 31, 2018	$ 30	88,801	(52,279)	36,552
Balance (in Shares) at Dec. 31, 2018	29,910
Common stock issued for cash, net of issuance costs	$ 8	28,733		28,741
Common stock issued for cash, net of issuance costs (in Shares)	7,362
Common stock issued for services		2,125		2,125
Common stock issued for services (in Shares)	46
Common stock issued for exercise of warrants
Common stock issued for exercise of warrants (in Shares)	16
Common stock issued for exercise of options		133		133
Common stock issued for exercise of options (in Shares)	19
Vesting of restricted shares		80		80
Repurchase of common shares
Repurchase of common shares (in Shares)	(21)
Common stock issued in payment of note interest		244		244
Common stock issued in payment of note interest (in Shares)	37
Net loss			(9,434)	(9,434)
Balance at Mar. 31, 2019	$ 30	91,383	(61,713)	29,700
Balance (in Shares) at Mar. 31, 2019	30,008
Common stock issued for cash, net of issuance costs
Common stock issued for cash, net of issuance costs (in Shares)	1
Balance at Jun. 30, 2019	$ 30	93,399	(67,475)	25,955
Balance (in Shares) at Jun. 30, 2019	30,141
Common stock issued for services		1,703		1,703
Common stock issued for services (in Shares)	283
Common stock issued for exercise of warrants
Common stock issued for exercise of warrants (in Shares)	6
Vesting of restricted shares		303		303
Common stock issued in payment of note interest		244		244
Common stock issued in payment of note interest (in Shares)	38
Net loss			(8,975)	(8,975)
Balance at Sep. 30, 2019	$ 30	95,649	(76,450)	19,229
Balance (in Shares) at Sep. 30, 2019	30,468
Balance at Jun. 30, 2019	$ 30	93,399	(67,475)	25,955
Balance (in Shares) at Jun. 30, 2019	30,141
Net loss				(26,063)
Balance at Mar. 31, 2020	$ 36	131,997	(93,538)	38,495
Balance (in Shares) at Mar. 31, 2020	36,352
Balance at Sep. 30, 2019	$ 30	95,649	(76,450)	19,229
Balance (in Shares) at Sep. 30, 2019	30,468
Common stock issued for services		1,602		1,602
Common stock issued for services (in Shares)	178
Common stock issued for exercise of warrants
Common stock issued for exercise of warrants (in Shares)	68
Common stock issued for exercise of options		55		55
Common stock issued for exercise of options (in Shares)	10
Common stock issued for equipment purchase		40		40
Common stock issued for equipment purchase (in Shares)	5
ESPP purchase		168		168
ESPP purchase (in Shares)	28
Common stock issued in payment of note interest		244		244
Common stock issued in payment of note interest (in Shares)	34
Repurchase and retirement of common shares
Repurchase and retirement of common shares (in Shares)	(99)
Net loss			(9,314)	(9,314)
Balance at Dec. 31, 2019	$ 36	129,922	(85,764)	44,194
Balance (in Shares) at Dec. 31, 2019	36,212
Common stock issued for cash, net of issuance costs	$ 6	32,164		32,170
Common stock issued for cash, net of issuance costs (in Shares)	5,520
Common stock issued for services		1,803		1,803
Common stock issued for services (in Shares)	105
Common stock issued for exercise of options		9		9
Common stock issued for exercise of options (in Shares)	2
Repurchase and retirement of common shares
Repurchase and retirement of common shares (in Shares)	(1)
Common stock issued in payment of note interest		244		244
Common stock issued in payment of note interest (in Shares)	34
Net loss			(7,774)	(7,774)
Balance at Mar. 31, 2020	$ 36	131,997	(93,538)	38,495
Balance (in Shares) at Mar. 31, 2020	36,352
Common stock issued for cash, net of issuance costs		$ 19		$ 19

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (26,063)	$ (23,487)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,194	1,815
Common stock issued for services	5,108	5,522
Amortization of debt discount	2,333	1,347
Change in fair value of derivative liabilities	(396)	1,372
Amortization of operating lease right of use asset	91
Loss on disposal of fixed assets		(38)
Non cash interest payment	731	777
Change in fair value of contingent real estate liability	(446)	(805)
Changes in operating assets and liabilities:
Accounts receivable	(407)	55
Inventory	18	(92)
Other current assets	477	(60)
Other assets	(188)	(188)
Accounts payable and accrued expenses	195	410
Lease liabilities	(85)
Change in other long-term liabilities		19
Deferred revenue	(5)	(66)
Net Cash Used in Operating Activities	(16,443)	(13,419)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for machinery and equipment	(6,340)	(4,436)
Cash received from sale of assets held for sale	28	33
Cash paid for intangibles	(143)	(92)
Net Cash Used in Investing Activities	(6,455)	(4,495)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	32,189	28,659
Proceeds from stock option exercises	64	133
Proceeds from employee stock purchase plan	168
Proceeds from the exercise of warrants		71
Proceeds received from convertible note, net of issuance costs		8,867
Net Cash Provided by Financing Activities	32,421	37,730
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash	9,523	19,816
Cash, Cash Equivalents and Restricted Cash - Beginning of Period	30,154	14,817
Cash, Cash Equivalents and Restricted Cash - End of Period	39,677	34,633
Cash Paid During the Period for:
Interest	488	256
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrued interest paid in common shares	731	777
Stock compensation payable	303	203
ASC 606 transition adjustment		20
Convertible Notes – Beneficial Conversion Feature		3,951
Reclass from assets held for sale	(251)
Assets purchase using common stock	40
Fixed assets in accounts payable	$ 290

Organization

Organization	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Nature of Operations [Text Block]	Note 1. Organization Akoustis Technologies, Inc. (“the Company”) was incorporated under the laws of the State of Nevada on April 10, 2013. Effective December 15, 2016, the Company changed its state of incorporation from the State of Nevada to the State of Delaware. Through its subsidiary, Akoustis, Inc. (a Delaware corporation), the Company, headquartered in Huntersville, North Carolina, is focused on developing, designing, and manufacturing innovative radio frequency (“RF”) filter products for the wireless industry, including for products such as smartphones and tablets, cellular infrastructure equipment, WiFi Customer Premise Equipment (“CPE”), and military and defense communication applications. Located between the device’s antenna and its digital backend, the RF front-end (“RFFE”) is the circuitry that performs the analog signal processing and contains components such as amplifiers, filters and switches. To construct the resonator devices that are the building blocks for its RF filters, the Company has developed a family of novel, high purity acoustic piezoelectric materials as well as a unique microelectromechanical system (“MEMS”) wafer process, collectively referred to as XBAW™ technology. The Company leverages its integrated device manufacturing (“IDM”) business model to develop and sell high performance RF filters using its XBAW TM

Liquidity

Liquidity	9 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidation Basis of Accounting [Text Block]	Note 2. Liquidity At March 31, 2020, the Company had cash and cash equivalents of $39.6 million and working capital of $37.5 million. The Company has historically incurred recurring operating losses and has experienced net cash used in operating activities of $16.4 million for the nine months ended March 31, 2020 which raises substantial doubt about the Company’s ability to continue as a going concern within one year after the issuance date. As of April 24, 2020, the Company had $38.4 million of cash and cash equivalents, which the Company expects to be sufficient to fund its operations beyond the next twelve months from the date of filing of this Form 10-Q. These funds will be used to fund the Company’s operations, including capital expenditures, R&D, commercialization of our technology, development of our patent strategy and expansion of our patent portfolio, as well as to provide working capital and funds for other general corporate purposes. The Company has no commitments to obtain any additional funds, and there can be no assurance such funds will be available on acceptable terms or at all. If the Company is unable to obtain additional financing in a timely fashion and on acceptable terms, its financial condition and results of operations may be materially adversely affected and it may not be able to continue operations or execute its stated commercialization plan.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 3. Summary of Significant Accounting Policies Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered necessary for a fair presentation have been included. The Company has evaluated subsequent events through the filing of this Form 10-Q. Operating results for the quarter ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020 or any future interim period. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Form 10-K filed with the SEC on September 13, 2019 (the “2019 Annual Report”). Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Akoustis, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation. Significant Accounting Policies and Estimates The Company’s significant accounting policies are disclosed in Note 3-Summary of Significant Accounting Policies in the 2019 Annual Report. Since the date of the 2019 Annual Report, other than adopting ASC 842 “Leases” discussed in the footnote below, there have been no material changes to the Company’s significant accounting policies. The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and the accompanying notes thereto. The policies, estimates and assumptions include valuing equity securities and derivative financial instruments issued in financing transactions, deferred taxes and related valuation allowances, revenue recognition, contingent real estate liability and the fair values of long-lived assets. Actual results could differ from the estimates. Shares Outstanding Shares outstanding include shares of restricted stock with respect to which restrictions have not lapsed. Shares of restricted stock are included in the calculation of weighted average shares outstanding. Restricted stock included in reportable shares outstanding were as follows as of March 31, 2020 and 2019. March 31, March 31, Shares of restricted stock included in reportable shares outstanding 116,250 311,328 Reclassification Certain prior period amounts have been reclassified to conform to current period presentation. The reclassifications did not have an impact on net loss as previously reported . Restricted Cash Restricted cash at March 31, 2020 and June 30, 2019 represents a retained balance obligation included in a deposit account control agreement required by the Company’s 6.5% Convertible Senior Secured Notes due 2023 issued in May 2018. The restriction on the cash will lapse in conjunction with the extinguishment of the debt. Recently Issued Accounting Pronouncements Accounting Pronouncements Recently Adopted In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842),” with multiple amendments subsequently issued. The new guidance requires that lease arrangements be presented on the lessee’s balance sheet by recording a right-of-use asset and a lease liability equal to the present value of the related future minimum lease payments. The Company adopted the standard in the first quarter of fiscal 2020, using the modified retrospective approach which permits lessees to recognize a cumulative-effect adjustment to the opening balance of accumulated deficit in the period of adoption. Upon adoption, the Company recorded a right-of-use asset of $0.7 million and a lease liability of $0.7 million. The Company elected the transition package of practical expedients, under which the Company does not have to reassess (1) whether any expired or existing contracts are leases, or contain leases, (2) the lease classification for any expired or existing leases, and (3) initial direct costs for any existing leases. Further, the Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude leases with an initial term of 12 months or less from the balance sheet. This standard did not have a material impact on the Condensed Consolidated Statement of Operations or Condensed Consolidated Statement of Cash Flows. See Note 12 for further disclosures resulting from the adoption of this new standard. In June 2018, the FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting In May 2017, the FASB issued ASU 2017-09, “ Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting,”

Revenue Recognition from Contra

Revenue Recognition from Contracts with Customers	9 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	Note 4. Revenue Recognition from Contracts with Customers Disaggregation of Revenue The Company’s primary revenue streams include foundry fabrication services and product sales. Foundry Fabrication Services Foundry fabrication services revenue includes microelectromechanical systems (“MEMS”) foundry services and Non-Recurring Engineering (“NRE”). Under these contracts, products are delivered to the customer at the completion of the service which represents satisfaction of the performance obligation as well as transfer of title. Depending on language with regards to enforceable right to payment for performance completed to date, related revenue will either be recognized over time or at a point in time. Product Sales Product sales revenue consists of sales of RF filters and amps, which are sold with contract terms stating that title passes, and the customer takes control, at the time of shipment. Revenue is then recognized when the devices are shipped, and the performance obligation has been satisfied. If devices are sold under contract terms that specify that the customer does not take ownership until the goods are received, revenue is recognized when the customer receives the goods. The following table summarizes the revenues of the Company’s reportable segments for the three months ended March 31, 2020 (in thousands): Foundry Services Product Sales Total MEMS $ 8 $ — $ 8 NRE - RF Filters 224 — 224 Filters/Amps — 131 131 Total $ 232 $ 131 $ 363 The following table summarizes the revenues of the Company’s reportable segments for the nine months ended March 31, 2020 (in thousands): Foundry Services Product Sales Total MEMS $ 265 $ — $ 265 NRE - RF Filters 652 — 652 Filters/Amps — 507 507 Total $ 917 $ 507 $ 1,424 The following table summarizes the revenues of the Company’s reportable segments for the three months ended March 31, 2019 (in thousands): Foundry Services Product Sales Total Customers MEMS $ 30 $ — $ 30 NRE - RF Filters 129 — 129 Filters/Amps — 78 78 Total $ 159 $ 78 $ 237 The following table summarizes the revenues of the Company’s reportable segments for the nine months ended March 31, 2019 (in thousands): Foundry Services Product Sales Total MEMS $ 175 $ — $ 175 NRE - RF Filters 392 — 392 Filters/Amps — 197 197 Total $ 567 $ 197 $ 764 Performance Obligations The Company has determined that contracts for product sales revenue and foundry fabrication services revenue involve one performance obligation, which is delivery of the final product. Contract Balances The Company records a receivable when the title for goods has transferred. Generally, all sales are contract sales (with either an underlying contract or purchase order), resulting in all receivables being contract receivables. When invoicing occurs prior to revenue recognition a contract liability is recorded (as deferred revenue on the Condensed Consolidated Balance Sheet). The following table summarizes the changes in the opening and closing balances of the Company’s contract asset and liability for the nine months ended March 31, 2020 and 2019 (in thousands): Contract Assets Contract Liabilities Balance, June 30, 2019 $ 140 $ 5 Closing, March 31, 2020 96 — Increase/(Decrease) (44 ) (5 ) Balance, June 30, 2018 $ 7 $ 53 Closing, March 31, 2019 57 4 Increase/(Decrease) 50 (49 ) The amount of revenue recognized in the nine months ended March 31, 2020 that was included in the opening contract liability balance was $5 thousand, which related to filter sales. The amount of revenue recognized in the nine months ended March 31, 2019 that was included in the opening contract liability balance consisted of $28 thousand that related to non-recurring engineering sales and $25 thousand that related to MEMS business. Contract assets are recorded when revenue recognized exceeds the amount invoiced. The difference between the opening and closing balances of the Company’s contract assets and contract liabilities primarily results from the timing difference between the Company’s performance and the customer’s payment. The amount of contract assets invoiced in the nine months ended March 31, 2020 that was included in the opening contract asset balance was $140 thousand, which primarily related to MEMS business. Backlog of Remaining Customer Performance Obligations Revenue expected to be recognized and recorded as sales during this fiscal year from the backlog of performance obligations that are unsatisfied (or partially unsatisfied) was $0.3 million at March 31, 2020 and was $0.2 million at March 31, 2019. Grant Revenue From time to time the Company applies for grants from various government bodies (state & federal), such as the National Science Foundation (“NSF”) or the Department of Defense (DoD), to support research and development. In addition, the Company is eligible for “matching awards” from state boards to provide additional funds to the Company to supplement the funds awarded under the federal grant program. The Company records grant revenue as a part of revenue from operations given that grant revenue is viewed as an ongoing function of its intended operations. The revenue from grants is not viewed as “incidental” or “peripheral” which would result in the presentation of grant revenue as “Other income”. The Company recognizes non-refundable grant revenue when the performance obligations have been met, application has been submitted and approval is reasonably assured.

Common Stock Equivalents

Common Stock Equivalents	9 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 5. Common Stock Equivalents The Company had the following common stock equivalents at March 31, 2020 and 2019. These are excluded from the loss per share calculation as they are considered anti-dilutive. March 31, March 31, Convertible Notes 4,960,800 4,960,800 Options 2,265,165 2,177,314 Warrants 541,999 708,651 Total 7,767,964 7,846,765

Property and Equipment, net

Property and Equipment, net	9 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 6. Property and Equipment, net Property and equipment, net consisted of the following as of March 31, 2020 and June 30, 2019 (in thousands): Estimated Useful Life March 31, June 30, Land n/a $ 1,000 $ 1,000 Building 11 years 3,000 3,000 Equipment 2-10 years 20,381 13,611 Leasehold Improvements * 949 949 Software 3 years 214 161 Furniture & Fixtures 5 years 11 11 Computer Equipment 3 years 260 203 Total 25,815 18,935 Less: Accumulated depreciation (5,873 ) (3,757 ) Total $ 19,942 $ 15,178 (*) Leasehold improvements are amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever is shorter. The Company recorded depreciation expense of $0.7 million and $0.6 million for the three months ended March 31, 2020 and 2019, respectively. The Company recorded depreciation expense of $2.2 million and $1.8 million for the nine months ended March 31, 2020 and 2019, respectively.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	9 Months Ended
	Mar. 31, 2020
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	Note 7. Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consisted of the following at March 31, 2020 and June 30, 2019 (in thousands): March 31, June 30, Accounts payable $ 607 $ 245 Accrued salaries and benefits 1,619 1,552 Accrued professional fees 140 315 Accrued utilities 117 193 Accrued interest 135 135 Accrued goods received not invoiced 127 69 Other accrued expenses 648 702 Totals $ 3,393 $ 3,211

Derivative Liabilities

Derivative Liabilities	9 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	Note 8. Derivative Liabilities The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended March 31, 2020 (in thousands): Fair Value Measurement Using Level 3 Inputs Total Balance, June 30, 2019 $ 955 Change in fair value of derivative liabilities (included in other (expense) income) (396 ) Balance, March 31, 2020 (see footnote 9) $ 559 The fair value of the derivative features of the convertible note at the balance sheet dates were calculated using the with-and-without method, a form of the income approach, valued with the following weighted average assumptions: March 31, June 30, Remaining term (years) 3.16-3.67 3.92 Expected volatility 60 % 49 % Risk free interest rate 0.30%-0.32 % 1.73 % Dividend yield 0.00 0.00 % Risk-free interest rate: Dividend yield: Volatility: Remaining term:

Convertible Notes

Convertible Notes	9 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 9. Convertible Notes The following table summarizes convertible debt as of March 31, 2020 (in thousands): Maturity Date Stated Interested Rate Conversion Price Face Value Remaining Debt (Discount) Fair Value of Embedded Conversion Option Carrying Value Long Term convertible notes payable 6.5% convertible senior secured notes 5/31/2023 6.50% $ 5.00 $ 15,000 $ (4,753 ) $ 439 $ 10,686 6.5% convertible senior notes 11/30/2023 6.50% $ 5.10 10,000 (654 ) 120 9,466 Ending Balance as of March 31, 2020 $ 25,000 $ (5,407 ) $ 559 $ 20,152 The following table summarizes convertible debt as of June 30, 2019 (in thousands): Maturity Date Stated Interested Rate Conversion Price Face Value Remaining Debt (Discount) Fair Value of Embedded Conversion Option Carrying Value Long Term convertible notes payable 6.5% convertible senior secured notes 5/31/2023 6.50% $ 5.00 $ 15,000 $ (6,825 ) $ 955 $ 9,130 6.5% convertible senior notes 11/30/2023 6.50% $ 5.10 10,000 (915 ) — 9,085 Ending Balance as of June 30, 2019 $ 25,000 $ (7,740 ) $ 955 $ 18,215

Concentrations

Concentrations	9 Months Ended
	Mar. 31, 2020
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	Note 10. Concentrations Vendors Vendor concentration as a percentage of purchases for the three months ended March 31, 2020 and 2019 are as follows: Three Months Three Months Vendor 1 — 21 % Vendor concentration as a percentage of purchases for the nine months ended March 31, 2020 and 2019 are as follows: Nine Months Nine Months Vendor 1 13 % — Customers Customer concentration as a percentage of revenue for the three months ended March 31, 2020 and 2019 are as follows: Three Months Three Months Customer 1 38 % 28 % Customer 2 33 % — Customer 3 12 % — Customer 4 11 % — Customer 5 — 21 % Customer 6 — 23 % Customer concentration as a percentage of revenue (excluding grant revenue) for the nine months ended March 31, 2020 and 2019 are as follows: Nine Months Nine Months Customer 1 20 % 22 % Customer 2 11 % — Customer 3 13 % — Customer 4 17 % 12 % Customer 5 22 % — Customer 6 — 14 % Customer 7 — 11 %

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Mar. 31, 2020
Disclosure Text Block Supplement [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	Note 11. Stockholders’ Equity Underwritten Public Offering of Common Stock During the nine months ended March 31, 2020, the Company sold a total of 5,520,000 shares of its common stock at a price to the public of $6.25 per share for aggregate gross proceeds of $34.5 million before deducting the underwriting discount and offering expenses payable by the Company of approximately $2.3 million. The Company expects to use the proceeds of the offering to fund the Company’s operations and growth of its business, including for capital expenditures, working capital, research and development, the commercialization of its technology and other general corporate purposes. Equity Incentive Plans During the nine months ended March 31, 2020, the Company granted employees and directors options to purchase an aggregate of 222,500 shares of common stock with a weighted average grant date fair value of $4.26. The fair values of the Company’s options were estimated at the dates of grant using a Black-Scholes option pricing model with the following weighted average assumptions: Nine Months March 31, Exercise price $ 4.71 - 8.09 Expected term (years) 4.75 – 5.00 Risk-free interest rate 0.64% – 1.74% Volatility 65 - 67% Dividend yield 0% Weighted Average Grant Date Fair Value of Options granted during the period $4.26 Expected term: The Company’s expected term is based on the period the options are expected to remain outstanding. The Company estimated this amount utilizing the “Simplified Method” in that the Company does not have sufficient historical experience to provide a reasonable basis to estimate an expected term. Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant. Volatility: The Company calculates the expected volatility of the stock price using the historical volatilities of the Company’s common stock traded on the Nasdaq Capital Market. Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future. During the nine months ended March 31, 2020 the Company awarded certain employees and contractors grants of an aggregate of 872,061 restricted stock units (“RSUs”) with a weighted average grant date fair value of $7.65. The RSUs will be expensed over the requisite service period. The terms of the RSUs include vesting provisions based solely on continued service. If the service criteria are satisfied, the RSUs will generally vest over 4 – 5 years. Compensation expense related to our stock-based awards described above was as follows (in thousands): Three Months Ended Nine Months Ended 2020 2019 2020 2019 Research and Development $ 929 $ 1,468 $ 2,675 $ 3,027 General and Administrative 874 787 2,433 2,495 Total $ 1,803 $ 2,255 $ 5,108 $ 5,522 Unrecognized stock-based compensation expense and weighted-average years to be recognized are as follows (in thousands): As of March 31, 2020 Unrecognized stock- based Weighted- Options $ 2,147 2.06 Restricted stock awards/units $ 7,203 2.09

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 12. Commitments and Contingencies Leases The Company leases office space and office equipment in Huntersville, NC as well as equipment in Canandaigua, NY. On January 7, 2020, the Company entered into an amended lease agreement with the current lessor in order to extend the lease term and increase office space at our Huntersville, NC corporate office. The amended lease expands our space to 22,000 square feet and extends the term to February 2023. This resulted in a remeasurement of the previous right of use liability which resulted in an increase of approximately $0.2 million. Following adoption of ASC 842, lease expense excludes capital area maintenance and property taxes. The components of lease expense were as follows (in thousands): Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended Operating Lease Expense $ 55 $ 51 $ 144 $ 161 Supplemental balance sheet information related to leases was as follows (in thousands): Classification on the March 31, Assets Operating lease assets Other non-current assets $ 751 Liabilities Other current liabilities Current liabilities 223 Operating lease liabilities Other non-current liabilities 534 Weighted Average Remaining Lease Term: Operating leases 2.9 Years Weighted Average Discount Rate: Operating leases 12.47 % The following table outlines the minimum future lease payments for the next five years and thereafter, (in thousands): For the year ending June 30, 2020 $ 76 2021 305 2022 312 2023 204 2024 7 Thereafter — Total lease payments (Undiscounted cash flows) 904 Less imputed interest (147 ) Total $ 757 Ontario County Industrial Development Authority Agreement On February 27, 2018, the Company entered into a Lease and Project Agreement (the “Lease and Project Agreement”) and a Company Lease Agreement (the “Company Lease Agreement” and together with the Lease and Project Agreement, the “Agreements”), each dated as of February 1, 2018, with the Ontario County Industrial Development Agency, a public benefit corporation of the State of New York (the “OCIDA”). Pursuant to the Agreements, the Company leases for $1.00 annually to the OCIDA an approximately 9.995 acre parcel of land in Canandaigua, New York, together with the improvements thereon (including the Company’s New York fabrication facility), and transferred title to certain related equipment and personal property to the OCIDA (collectively, the “Facility”). The OCIDA leases the Facility back to the Company for annual rent payments specified in the Lease and Project Agreement for the Company’s primary use as research and development, manufacturing, warehouse and professional office space in its business, and subleased, in part, by the Company to various tenants. The Company estimates substantial tax savings during the term of the Agreements, which expire on December 31, 2028. In addition, subject to the terms of the Lease and Project Agreement, certain purchases and leases of eligible items will be exempt from the imposition of sales and use taxes. Subject to the terms of the Lease and Project Agreement, the OCIDA has also granted to the Company an exemption from certain mortgage recording taxes for one or more mortgages securing an aggregate principal amount not to exceed $12.0 million, or such greater amount as approved by the OCIDA in its sole and absolute discretion. The benefits provided to the Company pursuant to the terms of the Lease and Project Agreement are subject to clawback over the life of the Agreements upon certain recapture events, including certain events of default. Real Estate Contingent Liability On March 23, 2017, we entered into an Asset Purchase Agreement and a Real Property Purchase Agreement (collectively, the “STC-MEMS Agreements”) with The Research Foundation for the State University of New York (“RF-SUNY”) and Fuller Road Management Corporation (“FRMC”), an affiliate of RF-SUNY (collectively, “Sellers”), respectively, to acquire certain specified assets, including STC-MEMS, a semiconductor wafer-manufacturing and MEMS operation with associated wafer-manufacturing tools, and the associated real estate and improvements located in Canandaigua, NY used in the operation of STC-MEMS (the assets and real estate and improvements referred to together herein as the “STC-MEMS Business”). In connection with the acquisition of the STC-MEMS Business, the Company agreed to pay to FRMC a penalty, if the Company sold the property subject to the related Definitive Real Property Purchase Agreement within three (3) years after the date of such agreement for an amount in excess of $1.75 million, subject to certain enumerated exceptions. The penalty imposed would have been equivalent to the amount that the sales price of the property exceeded $1.75 million up to a maximum penalty. Due to the lapse of the three-year penalty period, the maximum penalty as of March 31, 2020 was $0. Maximum Year 3, ending March 23, 2020 $ — The fair value of the contingent liability was reduced to zero due to the lapse of the sale restriction period. As of March 31, 2020, and June 30, 2019, the fair value of the contingent liability was $0.0 million and $0.4 million, respectively. During the three months ended March 31, 2020 and 2019, the Company marked the contingent liability to fair value and recorded a gain of $0.48 million and $0.91 million, respectively, relating to the change in fair value. During the nine months ended March 31, 2020 and 2019, the Company marked the contingent liability to fair value and recorded a gain of $0.45 million and $0.80 million, respectively, relating to the change in fair value. Litigation, Claims and Assessments From time to time, the Company may become involved in lawsuits, investigations and claims that arise in the ordinary course of business. The Company believes it has meritorious defenses against all pending claims and intends to vigorously pursue them. While it is not possible to predict or determine the outcomes of any pending actions, the Company believes the amount of liability, if any, with respect to such actions, would not materially affect its financial position, results of operations or cash flows. Effective November 5, 2018, the employment by the Company of its former principal financial officer, John T. Kurtzweil (the “Former CFO”), ended, after which the Former CFO filed for an arbitration hearing pursuant to the terms of his employment agreement and filed a complaint under the whistleblower provisions of the Sarbanes-Oxley Act of 2002 with the Occupational Safety and Health Administration (“OSHA”) of the U.S. Department of Labor. On October 28, 2019, the Company and the Former CFO entered into a Settlement Agreement that resolved all pending disputes between the parties with no admission of liability by either party. OSHA approved the Settlement Agreement and closed its investigation of the Former CEO’s whistleblower complaint on November 26, 2019. Pursuant to the Settlement Agreement, the Company paid the Former CFO an all-inclusive settlement amount of $375 thousand in cash. As part of the Settlement Agreement, all unvested restricted stock units and stock options were acknowledged as forfeited as of such date. The arbitration was closed on December 30, 2019. Tax Credit Contingency The Company accrues a liability for indirect tax contingencies when it believes that it is both probable that a liability has been incurred and that it can reasonably estimate the amount of the loss. The Company reviews these accruals and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the Company’s views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company’s accrued liabilities would be recorded in the period in which such determination is made. The Company’s gross unrecognized indirect tax credits totaled $0.1 million as of March 31, 2020 and $0.1 million as of June 30, 2019 and is recorded on the Consolidated Balance Sheet as a long-term liability.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 13. Related Party Transactions Consulting Services Total stock-based compensation expense related to stock-based awards granted in prior years for consulting services provided by a firm owned by one of the Co-Chairmen of the Company’s board of directors was $8 thousand and $17 thousand for the three months ended March 31, 2020 and 2019, respectively, and $32 thousand and $32 thousand for the nine months ended March 31, 2020 and 2019, respectively. Equipment Purchase On October 11, 2019, the Company issued 2,500 shares of common stock to the brother of the Company’s Chief Executive Officer in exchange for equipment with a fair market value of $20,000.

Segment Information

Segment Information	9 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	Note 14. Segment Information Operating segments are defined as components of an enterprise about which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company operates in two segments, Foundry Fabrication Services, which consists of engineering review services, and STC-MEMS foundry services, and RF Product, which consists of amplifier and filter product sales, and grant revenue. The Company records all general and administrative costs in the RF Product segment. The Company evaluates performance of its operating segments based on revenue and operating profit (loss). Segment information for the three and nine months ended March 31, 2020 and 2019 are as follows (in thousands): Foundry/ RF Product Total Three months ended March 31, 2020 Revenue with customers $ 232 $ 131 $ 363 Total Revenue 232 131 363 Cost of revenue 138 79 217 Gross margin 94 52 146 Research and development — 5,769 5,769 General and administrative — 2,589 2,589 Income (Loss) from Operations $ 94 (8,306 ) (8,212 ) Three months ended March 31, 2019 Revenue with customers $ 159 $ 78 $ 237 Total Revenue 159 78 237 Cost of revenue 176 123 299 Gross margin (17 ) (45 ) (62 ) Research and development — 5,505 5,505 General and administrative — 2,503 2,503 Income (Loss) from Operations $ (17 ) $ (8,053 ) (8,070 ) Nine months ended March 31, 2020 Revenue with customers $ 917 $ 507 $ 1,424 Total Revenue 917 507 1,424 Cost of revenue 545 795 1,340 Gross margin 372 (288 ) 84 Research and development — 15,736 15,736 General and administrative — 8,158 8,158 Income (Loss) from Operations $ 372 (24,182 ) (23,810 ) Nine months ended March 31, 2019 Revenue with customers $ 567 $ 197 $ 764 Grant revenue — 109 109 Total Revenue 567 306 873 Cost of revenue 666 147 813 Gross margin (99 ) 159 60 Research and development — 14,340 14,340 General and administrative — 6,841 6,841 Income (Loss) from Operations $ (99 ) $ (21,022 ) (21,121 ) As of March 31, 2020 Accounts receivable $ 574 $ 118 $ 692 Property and equipment, net — $ 19,942 $ 19,942 As of June 30, 2019 Accounts receivable $ 150 $ 135 $ 285 Property and equipment, net $ 54 $ 15,124 $ 15,178

Subsequent Events

Subsequent Events	9 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 15. Subsequent Events Supplemental Indentures On April 17, 2020, the Company entered into supplemental indentures to the indentures governing its outstanding 6.5% Convertible Senior Secured Notes due 2023 and its outstanding 6.5% Convertible Senior Notes due 2023. Among other things, the supplemental indentures permit the incurrence of indebtedness made available through the CARES Act and regulations thereunder.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered necessary for a fair presentation have been included. The Company has evaluated subsequent events through the filing of this Form 10-Q. Operating results for the quarter ended March 31, 2020 are not necessarily indicative of the results that may be expected for the year ending June 30, 2020 or any future interim period. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Form 10-K filed with the SEC on September 13, 2019 (the “2019 Annual Report”).
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, Akoustis, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.
Significant Accounting Policies and Estimates	Significant Accounting Policies and Estimates The Company’s significant accounting policies are disclosed in Note 3-Summary of Significant Accounting Policies in the 2019 Annual Report. Since the date of the 2019 Annual Report, other than adopting ASC 842 “Leases” discussed in the footnote below, there have been no material changes to the Company’s significant accounting policies. The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and the accompanying notes thereto. The policies, estimates and assumptions include valuing equity securities and derivative financial instruments issued in financing transactions, deferred taxes and related valuation allowances, revenue recognition, contingent real estate liability and the fair values of long-lived assets. Actual results could differ from the estimates.
Shares Outstanding	Shares Outstanding Shares outstanding include shares of restricted stock with respect to which restrictions have not lapsed. Shares of restricted stock are included in the calculation of weighted average shares outstanding. Restricted stock included in reportable shares outstanding were as follows as of March 31, 2020 and 2019. March 31, March 31, Shares of restricted stock included in reportable shares outstanding 116,250 311,328
Reclassification	Reclassification Certain prior period amounts have been reclassified to conform to current period presentation. The reclassifications did not have an impact on net loss as previously reported .
Restricted Cash	Restricted Cash Restricted cash at March 31, 2020 and June 30, 2019 represents a retained balance obligation included in a deposit account control agreement required by the Company’s 6.5% Convertible Senior Secured Notes due 2023 issued in May 2018. The restriction on the cash will lapse in conjunction with the extinguishment of the debt.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Accounting Pronouncements Recently Adopted In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, “Leases (Topic 842),” with multiple amendments subsequently issued. The new guidance requires that lease arrangements be presented on the lessee’s balance sheet by recording a right-of-use asset and a lease liability equal to the present value of the related future minimum lease payments. The Company adopted the standard in the first quarter of fiscal 2020, using the modified retrospective approach which permits lessees to recognize a cumulative-effect adjustment to the opening balance of accumulated deficit in the period of adoption. Upon adoption, the Company recorded a right-of-use asset of $0.7 million and a lease liability of $0.7 million. The Company elected the transition package of practical expedients, under which the Company does not have to reassess (1) whether any expired or existing contracts are leases, or contain leases, (2) the lease classification for any expired or existing leases, and (3) initial direct costs for any existing leases. Further, the Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude leases with an initial term of 12 months or less from the balance sheet. This standard did not have a material impact on the Condensed Consolidated Statement of Operations or Condensed Consolidated Statement of Cash Flows. See Note 12 for further disclosures resulting from the adoption of this new standard. In June 2018, the FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting In May 2017, the FASB issued ASU 2017-09, “ Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting,”

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]	March 31, March 31, Shares of restricted stock included in reportable shares outstanding 116,250 311,328

Revenue Recognition from Cont_2

Revenue Recognition from Contracts with Customers (Tables)	9 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	Foundry Services Product Sales Total MEMS $ 8 $ — $ 8 NRE - RF Filters 224 — 224 Filters/Amps — 131 131 Total $ 232 $ 131 $ 363 Foundry Services Product Sales Total MEMS $ 265 $ — $ 265 NRE - RF Filters 652 — 652 Filters/Amps — 507 507 Total $ 917 $ 507 $ 1,424 Foundry Services Product Sales Total Customers MEMS $ 30 $ — $ 30 NRE - RF Filters 129 — 129 Filters/Amps — 78 78 Total $ 159 $ 78 $ 237 Foundry Services Product Sales Total MEMS $ 175 $ — $ 175 NRE - RF Filters 392 — 392 Filters/Amps — 197 197 Total $ 567 $ 197 $ 764
Contract with Customer, Asset and Liability [Table Text Block]	Contract Assets Contract Liabilities Balance, June 30, 2019 $ 140 $ 5 Closing, March 31, 2020 96 — Increase/(Decrease) (44 ) (5 ) Balance, June 30, 2018 $ 7 $ 53 Closing, March 31, 2019 57 4 Increase/(Decrease) 50 (49 )

Common Stock Equivalents (Table

Common Stock Equivalents (Tables)	9 Months Ended
	Mar. 31, 2020
Stockholders' Equity Note [Abstract]
Schedule of Common Stock Equivalents [Table Text Block]	March 31, March 31, Convertible Notes 4,960,800 4,960,800 Options 2,265,165 2,177,314 Warrants 541,999 708,651 Total 7,767,964 7,846,765

Property and Equipment, net (Ta

Property and Equipment, net (Tables)	9 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Estimated Useful Life March 31, June 30, Land n/a $ 1,000 $ 1,000 Building 11 years 3,000 3,000 Equipment 2-10 years 20,381 13,611 Leasehold Improvements * 949 949 Software 3 years 214 161 Furniture & Fixtures 5 years 11 11 Computer Equipment 3 years 260 203 Total 25,815 18,935 Less: Accumulated depreciation (5,873 ) (3,757 ) Total $ 19,942 $ 15,178 (*) Leasehold improvements are amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever is shorter.

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	9 Months Ended
	Mar. 31, 2020
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	March 31, June 30, Accounts payable $ 607 $ 245 Accrued salaries and benefits 1,619 1,552 Accrued professional fees 140 315 Accrued utilities 117 193 Accrued interest 135 135 Accrued goods received not invoiced 127 69 Other accrued expenses 648 702 Totals $ 3,393 $ 3,211

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	9 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Fair Value Measurement Using Level 3 Inputs Total Balance, June 30, 2019 $ 955 Change in fair value of derivative liabilities (included in other (expense) income) (396 ) Balance, March 31, 2020 (see footnote 9) $ 559
Schedule of Assumptions for Fair Value as of Balance Sheet Date of Assets or Liabilities that relate to Transferor's Continuing Involvement [Table Text Block]	March 31, June 30, Remaining term (years) 3.16-3.67 3.92 Expected volatility 60 % 49 % Risk free interest rate 0.30%-0.32 % 1.73 % Dividend yield 0.00 0.00 %

Convertible Notes (Tables)

Convertible Notes (Tables)	9 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Convertible Debt [Table Text Block]	Maturity Date Stated Interested Rate Conversion Price Face Value Remaining Debt (Discount) Fair Value of Embedded Conversion Option Carrying Value Long Term convertible notes payable 6.5% convertible senior secured notes 5/31/2023 6.50% $ 5.00 $ 15,000 $ (4,753 ) $ 439 $ 10,686 6.5% convertible senior notes 11/30/2023 6.50% $ 5.10 10,000 (654 ) 120 9,466 Ending Balance as of March 31, 2020 $ 25,000 $ (5,407 ) $ 559 $ 20,152 Maturity Date Stated Interested Rate Conversion Price Face Value Remaining Debt (Discount) Fair Value of Embedded Conversion Option Carrying Value Long Term convertible notes payable 6.5% convertible senior secured notes 5/31/2023 6.50% $ 5.00 $ 15,000 $ (6,825 ) $ 955 $ 9,130 6.5% convertible senior notes 11/30/2023 6.50% $ 5.10 10,000 (915 ) — 9,085 Ending Balance as of June 30, 2019 $ 25,000 $ (7,740 ) $ 955 $ 18,215

Concentrations (Tables)

Concentrations (Tables)	9 Months Ended
	Mar. 31, 2020
Risks and Uncertainties [Abstract]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	Three Months Three Months Vendor 1 — 21 % Nine Months Nine Months Vendor 1 13 % — Three Months Three Months Customer 1 38 % 28 % Customer 2 33 % — Customer 3 12 % — Customer 4 11 % — Customer 5 — 21 % Customer 6 — 23 % Nine Months Nine Months Customer 1 20 % 22 % Customer 2 11 % — Customer 3 13 % — Customer 4 17 % 12 % Customer 5 22 % — Customer 6 — 14 % Customer 7 — 11 %

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Mar. 31, 2020
Disclosure Text Block Supplement [Abstract]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Nine Months March 31, Exercise price $ 4.71 - 8.09 Expected term (years) 4.75 – 5.00 Risk-free interest rate 0.64% – 1.74% Volatility 65 - 67% Dividend yield 0% Weighted Average Grant Date Fair Value of Options granted during the period $4.26
Share-based Payment Arrangement, Activity [Table Text Block]	Three Months Ended Nine Months Ended 2020 2019 2020 2019 Research and Development $ 929 $ 1,468 $ 2,675 $ 3,027 General and Administrative 874 787 2,433 2,495 Total $ 1,803 $ 2,255 $ 5,108 $ 5,522
Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]	As of March 31, 2020 Unrecognized stock- based Weighted- Options $ 2,147 2.06 Restricted stock awards/units $ 7,203 2.09

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of Operating Lease Expense [Table Text Block]	Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended Operating Lease Expense $ 55 $ 51 $ 144 $ 161
Schedule of Balance Sheet Information Related To Leases [Table Text Block]	Classification on the March 31, Assets Operating lease assets Other non-current assets $ 751 Liabilities Other current liabilities Current liabilities 223 Operating lease liabilities Other non-current liabilities 534
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Weighted Average Remaining Lease Term: Operating leases 2.9 Years Weighted Average Discount Rate: Operating leases 12.47 %
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	For the year ending June 30, 2020 $ 76 2021 305 2022 312 2023 204 2024 7 Thereafter — Total lease payments (Undiscounted cash flows) 904 Less imputed interest (147 ) Total $ 757
Change in Closed Block Assets and Liabilities, Maximum Future Earnings to be Recognized [Table Text Block]	Maximum Year 3, ending March 23, 2020 $ —

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Foundry/ RF Product Total Three months ended March 31, 2020 Revenue with customers $ 232 $ 131 $ 363 Total Revenue 232 131 363 Cost of revenue 138 79 217 Gross margin 94 52 146 Research and development — 5,769 5,769 General and administrative — 2,589 2,589 Income (Loss) from Operations $ 94 (8,306 ) (8,212 ) Three months ended March 31, 2019 Revenue with customers $ 159 $ 78 $ 237 Total Revenue 159 78 237 Cost of revenue 176 123 299 Gross margin (17 ) (45 ) (62 ) Research and development — 5,505 5,505 General and administrative — 2,503 2,503 Income (Loss) from Operations $ (17 ) $ (8,053 ) (8,070 ) Nine months ended March 31, 2020 Revenue with customers $ 917 $ 507 $ 1,424 Total Revenue 917 507 1,424 Cost of revenue 545 795 1,340 Gross margin 372 (288 ) 84 Research and development — 15,736 15,736 General and administrative — 8,158 8,158 Income (Loss) from Operations $ 372 (24,182 ) (23,810 ) Nine months ended March 31, 2019 Revenue with customers $ 567 $ 197 $ 764 Grant revenue — 109 109 Total Revenue 567 306 873 Cost of revenue 666 147 813 Gross margin (99 ) 159 60 Research and development — 14,340 14,340 General and administrative — 6,841 6,841 Income (Loss) from Operations $ (99 ) $ (21,022 ) (21,121 ) As of March 31, 2020 Accounts receivable $ 574 $ 118 $ 692 Property and equipment, net — $ 19,942 $ 19,942 As of June 30, 2019 Accounts receivable $ 150 $ 135 $ 285 Property and equipment, net $ 54 $ 15,124 $ 15,178

Liquidity (Details)

Liquidity (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Apr. 24, 2020	Jun. 30, 2019
Liquidity (Details) [Line Items]
Cash	$ 39,600
Working capital	37,500
Net cash used in operating activities	16,400
Cash and cash equivalents	$ 39,577		$ 30,054
Subsequent Event [Member]
Liquidity (Details) [Line Items]
Cash and cash equivalents		$ 38,400

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Jun. 30, 2019
Summary of Significant Accounting Policies (Details) [Line Items]
Percentage Of Convertible Senior Secured Notes	6.50%
Operating Lease, Right-of-Use Asset	$ 751
Accrued Expenses With Share Based Compensation	300
Accounting Standards Update 2016-02 [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Operating Lease, Right-of-Use Asset	700
Operating Lease, Liability	$ 700

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of weighted average shares outstanding restricted stock included in reportable shares outstanding - shares	Mar. 31, 2020	Mar. 31, 2019
Restricted Stock Units (RSUs) [Member]
Summary of Significant Accounting Policies (Details) - Schedule of weighted average shares outstanding restricted stock included in reportable shares outstanding [Line Items]
Shares of restricted stock included in reportable shares outstanding	116,250	311,328

Revenue Recognition from Cont_3

Revenue Recognition from Contracts with Customers (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue Recognition from Contracts with Customers (Details) [Line Items]
Opening contract liability balance revenue recognized	$ 5	$ 28
Revenue expected to be recognized	300	200
MEMS [Member]
Revenue Recognition from Contracts with Customers (Details) [Line Items]
Opening contract liability balance revenue recognized	$ 140	$ 25

Revenue Recognition from Cont_4

Revenue Recognition from Contracts with Customers (Details) - Schedule of revenues of reportable segments - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Revenue, Major Customer [Line Items]
MEMS	$ 8	$ 30	$ 265	$ 175
NRE - RF Filters	224	129	652	392
Filters/Amps	131	78	507	197
Total	363	237	1,424	764
Foundry Fabrication Services Revenue [Member]
Revenue, Major Customer [Line Items]
MEMS	8	30	265	175
NRE - RF Filters	224	129	652	392
Filters/Amps
Total	232	159	917	567
Product Sales Revenue [Member]
Revenue, Major Customer [Line Items]
MEMS
NRE - RF Filters
Filters/Amps	131	78	507	197
Total	$ 131	$ 78	$ 507	$ 197

Revenue Recognition from Cont_5

Revenue Recognition from Contracts with Customers (Details) - Schedule of changes in contract asset and liability - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Contract Assets [Member]
Revenue Recognition from Contracts with Customers (Details) - Schedule of changes in contract asset and liability [Line Items]
Balance	$ 140	$ 7
Closing	96	57
Increase/(Decrease)	(44)	50
Contract Liability [Member]
Revenue Recognition from Contracts with Customers (Details) - Schedule of changes in contract asset and liability [Line Items]
Balance	5	53
Closing		4
Increase/(Decrease)	$ (5)	$ (49)

Common Stock Equivalents (Detai

Common Stock Equivalents (Details) - Schedule of common stock equivalents - shares	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Common Stock Equivalents (Details) - Schedule of common stock equivalents [Line Items]
Common stock equivalents, total	7,767,964	7,846,765
Convertible Debt Securities [Member]
Common Stock Equivalents (Details) - Schedule of common stock equivalents [Line Items]
Common stock equivalents, total	4,960,800	4,960,800
Share-based Payment Arrangement, Option [Member]
Common Stock Equivalents (Details) - Schedule of common stock equivalents [Line Items]
Common stock equivalents, total	2,265,165	2,177,314
Warrant [Member]
Common Stock Equivalents (Details) - Schedule of common stock equivalents [Line Items]
Common stock equivalents, total	541,999	708,651

Property and Equipment, net (De

Property and Equipment, net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 0.7	$ 0.6	$ 2.2	$ 1.8

Property and Equipment, net (_2

Property and Equipment, net (Details) - Schedule of property and equipment - USD ($) $ in Thousands		9 Months Ended
		Jun. 30, 2019	Mar. 31, 2020
Property, Plant and Equipment [Line Items]
Total gross		$ 18,935	$ 25,815
Less: Accumulated depreciation		(3,757)	(5,873)
Total		$ 15,178	19,942
Land [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life		n/a
Total gross		$ 1,000	1,000
Building [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life		11 years
Total gross		$ 3,000	3,000
Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life		2-10 years
Total gross		$ 13,611	20,381
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life	[1]
Total gross		$ 949	949
Software Development [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life		3 years
Total gross		$ 161	214
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life		5 years
Total gross		$ 11	11
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life		3 years
Total gross		$ 203	$ 260
[1]	Leasehold improvements are amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever is shorter.

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - Schedule of accounts payable and accrued expenses - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019
Schedule of accounts payable and accrued expenses [Abstract]
Accounts payable	$ 607	$ 245
Accrued salaries and benefits	1,619	1,552
Accrued professional fees	140	315
Accrued utilities	117	193
Accrued interest	135	135
Accrued goods received not invoiced	127	69
Other accrued expenses	648	702
Totals	$ 3,393	$ 3,211

Derivative Liabilities (Details

Derivative Liabilities (Details)	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Debt Instrument, Interest Rate, Effective Percentage	0.00%

Derivative Liabilities (Detai_2

Derivative Liabilities (Details) - Schedule of changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3)	9 Months Ended
	Mar. 31, 2020USD ($)
Schedule of changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) [Abstract]
Balance at beginning	$ 955
Change in fair value of derivative liabilities (included in other (expense) income)	(396)
Balance at ending	$ 559

Derivative Liabilities (Detai_3

Derivative Liabilities (Details) - Schedule of fair value of the derivative features of the convertible note at the balance sheet dates were calculated using the with-and-without method, a form of the income approach	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Jun. 30, 2019
Assumption for Fair Value as of Balance Sheet Date of Assets or Liabilities that relate to Transferor's Continuing Involvement [Line Items]
Remaining term (years)		3 years 335 days
Expected volatility	60.00%	49.00%
Risk free interest rate		1.73%
Dividend yield	0.00%	0.00%
Minimum [Member]
Assumption for Fair Value as of Balance Sheet Date of Assets or Liabilities that relate to Transferor's Continuing Involvement [Line Items]
Remaining term (years)	3 years 58 days
Risk free interest rate	0.30%
Maximum [Member]
Assumption for Fair Value as of Balance Sheet Date of Assets or Liabilities that relate to Transferor's Continuing Involvement [Line Items]
Remaining term (years)	3 years 244 days
Risk free interest rate	0.32%

Convertible Notes (Details) - S

Convertible Notes (Details) - Schedule of debt - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Jun. 30, 2019
Long Term convertible notes payable
Face Value	$ 25,000	$ 25,000
Remaining Debt (Discount)	(5,407)	(7,740)
Fair Value of Embedded Conversion Option	559	955
Carrying Value	$ 20,152	$ 18,215
6.5% Convertible Senior Secured Notes [Member]
Long Term convertible notes payable
Maturity date	May 31, 2023	May 31, 2023
Stated Interested Rate	6.50%	6.50%
Conversion price (in Dollars per share)	$ 5	$ 5
Face Value	$ 15,000	$ 15,000
Remaining Debt (Discount)	(4,753)	(6,825)
Fair Value of Embedded Conversion Option	439	955
Carrying Value	$ 10,686	$ 9,130
6.5% Convertible Senior Notes [Member]
Long Term convertible notes payable
Maturity date	Nov. 30, 2023	Nov. 30, 2023
Stated Interested Rate	6.50%	6.50%
Conversion price (in Dollars per share)	$ 5.10	$ 5.10
Face Value	$ 10,000	$ 10,000
Remaining Debt (Discount)	(654)	(915)
Fair Value of Embedded Conversion Option	120
Carrying Value	$ 9,466	$ 9,085

Concentrations (Details) - Sche

Concentrations (Details) - Schedule of concentration risk percentage	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Cost of Goods and Service Benchmark [Member] | Vendor 1 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		21.00%	13.00%
Cost of Goods and Service Benchmark [Member] | Customer 1 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			20.00%	22.00%
Cost of Goods and Service Benchmark [Member] | Customer 2 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			11.00%
Cost of Goods and Service Benchmark [Member] | Customer 3 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			13.00%
Cost of Goods and Service Benchmark [Member] | Customer 4 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			17.00%	12.00%
Cost of Goods and Service Benchmark [Member] | Customer 5 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			22.00%
Cost of Goods and Service Benchmark [Member] | Customer 6 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage				14.00%
Cost of Goods and Service Benchmark [Member] | Customer 7 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage				11.00%
Revenue Benchmark [Member] | Customer 1 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.00%	28.00%
Revenue Benchmark [Member] | Customer 2 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	33.00%
Revenue Benchmark [Member] | Customer 3 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	12.00%
Revenue Benchmark [Member] | Customer 4 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%
Revenue Benchmark [Member] | Customer 5 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		21.00%
Revenue Benchmark [Member] | Customer 6 [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		23.00%

Stockholders' Equity (Details)

Stockholders' Equity (Details) $ / shares in Units, $ in Millions	9 Months Ended
	Mar. 31, 2020USD ($)$ / sharesshares
Stockholders' Equity (Details) [Line Items]
Common stock, Shares | shares	5,520,000
Common stock, Value per share	$ 6.25
Aggregate gross value | $	$ 34.5
Payments for Underwriting Expense | $	$ 2.3
Weighted average grant fair value (in dollars per share)	$ 4.26
Dividend yield	0.00%
Restricted Stock Units (RSUs) [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate of restricted stock units | shares	222,500
Weighted average grant fair value (in dollars per share)	$ 4.26
Employees and Directors [Member]
Stockholders' Equity (Details) [Line Items]
Weighted average grant fair value (in dollars per share)	$ 7.65
Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Vesting period	4 years
Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Vesting period	5 years
Employees and Directors [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate of restricted stock units | shares	872,061

Stockholders' Equity (Details)

Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model	9 Months Ended
	Mar. 31, 2020$ / shares
Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model [Line Items]
Dividend yield	0.00%
Weighted Average Grant Date Fair Value of Options granted during the period (in Dollars per share)	$ 4.26
Minimum [Member]
Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model [Line Items]
Exercise price (in Dollars per share)	$ 4.71
Expected term (years)	4 years 9 months
Risk-free interest rate	0.64%
Volatility	65.00%
Maximum [Member]
Stockholders' Equity (Details) - Schedule of fair value of options were estimated at the dates of grant using a Black-Scholes option pricing model [Line Items]
Exercise price (in Dollars per share)	$ 8.09
Expected term (years)	5 years
Risk-free interest rate	1.74%
Volatility	67.00%

Stockholders' Equity (Details_2

Stockholders' Equity (Details) - Schedule of compensation expense related to our stock-based awards - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Schedule of compensation expense related to our stock-based awards [Abstract]
Research and Development	$ 929	$ 1,468	$ 2,675	$ 3,027
General and Administrative	874	787	2,433	2,495
Total	$ 1,803	$ 2,255	$ 5,108	$ 5,522

Stockholders' Equity (Details_3

Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense and weighted-average years $ / shares in Units, $ in Thousands	Mar. 31, 2020USD ($)$ / shares
Share-based Payment Arrangement, Option [Member]
Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense and weighted-average years [Line Items]
Unrecognized stock-based compensation | $	$ 2,147
Weighted-average years to be recognized | $ / shares	$ 2.06
Restricted Stock Units (RSUs) [Member]
Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense and weighted-average years [Line Items]
Unrecognized stock-based compensation | $	$ 7,203
Weighted-average years to be recognized | $ / shares	$ 2.09

Commitments and Contingencies_2

Commitments and Contingencies (Details)	Jan. 07, 2020USD ($)	Nov. 05, 2018USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Jun. 30, 2019USD ($)	Feb. 28, 2018USD ($)m²
Commitments and Contingencies (Details) [Line Items]
Lease term, description					The amended lease expands our space to 22,000 square feet and extends the term to February 2023.
Increase in right of use liability	$ 200,000
Penalty amount					$ 0
Discount rate					0.00%
Contingent liability			$ 0		$ 0		$ 400,000
Fair value and loss of contingent liability			480,000	$ 910,000	450,000	$ 800,000
Litigation Settlement, Amount Awarded to Other Party		$ 375,000
Gross unrecognized indirect tax credits totaled			$ 100,000		$ 100,000		$ 100,000
Asset Purchase Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Description of agreement					In connection with the acquisition of the STC-MEMS Business, the Company agreed to pay to FRMC a penalty, if the Company sold the property subject to the related Definitive Real Property Purchase Agreement within three (3) years after the date of such agreement for an amount in excess of $1.75 million, subject to certain enumerated exceptions.
Description of penalty					The penalty imposed would have been equivalent to the amount that the sales price of the property exceeded $1.75 million up to a maximum penalty.
OCIDA [Member] | Canandaigua, New York [Member] | Lease and Project Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Lease								$ 1
Acre parcel of land (in Square Meters) | m²								9.995
Mortgages securing an aggregate principal amount								$ 12,000,000

Commitments and Contingencies_3

Commitments and Contingencies (Details) - Schedule of operating lease expense - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Schedule of operating lease expense [Abstract]
Operating Lease Expense	$ 55	$ 51	$ 144	$ 161

Commitments and Contingencies_4

Commitments and Contingencies (Details) - Schedule of balance sheet information related to leases - USD ($) $ in Thousands	Mar. 31, 2020	Jun. 30, 2019
Assets
Operating lease assets	$ 751
Liabilities
Other current liabilities	223
Operating lease liabilities	$ 534

Commitments and Contingencies_5

Commitments and Contingencies (Details) - Schedule of Operating lease	Mar. 31, 2020
Weighted Average Remaining Lease Term:
Operating leases	2 years 328 days
Weighted Average Discount Rate:
Operating leases	12.47%

Commitments and Contingencies_6

Commitments and Contingencies (Details) - Schedule of minimum future lease payments $ in Thousands	Jun. 30, 2019USD ($)
Schedule of minimum future lease payments [Abstract]
2020	$ 76
2021	305
2022	312
2023	204
2024	7
Thereafter
Total lease payments (Undiscounted cash flows)	904
Less imputed interest	(147)
Total	$ 757

Commitments and Contingencies_7

Commitments and Contingencies (Details) - Schedule of future maximum penalty under the equivalent	9 Months Ended
	Mar. 31, 2020USD ($)
Schedule of future maximum penalty under the equivalent [Abstract]
Year 3, ending March 23, 2020

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Oct. 11, 2019
Related Party Transactions (Details) [Line Items]
Stock based compensation	$ 1,803,000	$ 2,255,000	$ 5,108,000	$ 5,522,000
Shares issued (in Shares)	5,520,000		5,520,000
Co-Chairman [Member]
Related Party Transactions (Details) [Line Items]
Stock based compensation	$ 8,000	$ 17,000
Board of Directors Chairman [Member]
Related Party Transactions (Details) [Line Items]
Stock based compensation			$ 32,000	$ 32,000
Chief Executive Officer [Member]
Related Party Transactions (Details) [Line Items]
Shares issued (in Shares)					2,500
Fair market value					$ 20,000

Segment Information (Details)

Segment Information (Details)	9 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Number of segments	2

Segment Information (Details) -

Segment Information (Details) - Schedule of operating segments based on revenue and operating profit - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019	Jun. 30, 2019
Foundry Fabrication Services Revenue [Member]
Segment Reporting Information [Line Items]
Revenue with customers	$ 232	$ 159	$ 917	$ 567
Grant revenue
Total Revenue	232	159	917	567
Cost of revenue	138	176	545	666
Gross margin	94	(17)	372	(99)
Research and development
General and administrative
Income (Loss) from Operations	94	(17)	372	(99)
Accounts receivable	574		574		$ 150
Property and equipment, net					54
RF Product [Member]
Segment Reporting Information [Line Items]
Revenue with customers	131	78	507	197
Grant revenue				109
Total Revenue	131	78	507	306
Cost of revenue	79	123	795	147
Gross margin	52	(45)	(288)	159
Research and development	5,769	5,505	15,736	14,340
General and administrative	2,589	2,503	8,158	6,841
Income (Loss) from Operations	(8,306)	(8,053)	(24,182)	(21,022)
Accounts receivable	118		118		135
Property and equipment, net	19,942		19,942		15,124
Total [Member]
Segment Reporting Information [Line Items]
Revenue with customers	363	237	1,424	764
Grant revenue				109
Total Revenue	363	237	1,424	873
Cost of revenue	217	299	1,340	813
Gross margin	146	(62)	84	60
Research and development	5,769	5,505	15,736	14,340
General and administrative	2,589	2,503	8,158	6,841
Income (Loss) from Operations	(8,212)	$ (8,070)	(23,810)	$ (21,121)
Accounts receivable	692		692		285
Property and equipment, net	$ 19,942		$ 19,942		$ 15,178

Subsequent Events (Details)

Subsequent Events (Details)	1 Months Ended
	Apr. 17, 2020
Subsequent Event [Member]
Subsequent Events (Details) [Line Items]
Subsequent events, description	On April 17, 2020, the Company entered into supplemental indentures to the indentures governing its outstanding 6.5% Convertible Senior Secured Notes due 2023 and its outstanding 6.5% Convertible Senior Notes due 2023.